Imagion Biosystems announces the presentation “MagSense® Imaging: Early Detection of Cancer Through Targeted Imaging.”
See the presentation “MagSense® Imaging“.
Positive Final Results of Wayne State Collaboration Drives Completion of Phase 2 Study Protocol for IND Submission to FDA in December
December 2, 2025
Positive Final Results of Wayne State Collaboration Drives Completion of Phase 2 Study Protocol for IND Submission to FDA in December Key Highlights: MagSense® HER2